Unbound MEDLINE

High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial. European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] Journal article

 
TitleHigh dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial.
Author(s)De Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R 
InstitutionInstitute of Endocrinology and Nutrition, Medicine School and Hospital Rio Hortega, Valladolid, Spain. dadluis@yahoo.es
SourceEur Rev Med Pharmacol Sci 2009 Jul-Aug; 13(4):279-83.
AbstractOBJECTIVE: Patients with head and neck cancer undergoing surgery have a high incidence of postoperative complications. The aim of our study was to investigate whether postoperative nutrition of head and neck cancer patients, using a higher dose of arginine (20 g per day) could improve nutritional variables.
MATERIALS AND METHODS: A population of 72 patients with oral and laryngeal cancer was enrolled. At surgery patients were randomly allocated to two groups: a) patients were receiving an enteral diet supplements with arginine and fiber (group I); b) patients were receiving an isocaloric, isonitrogenous enteral formula (group II).
RESULTS: No significant intergroup differences in the trend of the three serum proteins and lymphocytes were detected. Gastrointestinal tolerance (diarrhea) of both formulas was good (7.89% group I and 5.88% group II: ns). The postoperative infections complications were similar in both groups (23.6% group I and 20.6% group II: ns). Fistula was less frequent in enriched nutrition group (5.2% group I and 17.6% group II: p = 0.026). The length of postoperative stay was better 24.3 +/- 14 days in the immunonutrition group than 36.1 +/- 27 days in the control group (p = 0.036).
CONCLUSIONS: Enriched formula improves local wound complications in postoperative head and neck cancer patients and decreases length of stay.
Languageeng
Pub Type(s)Journal Article
PubMed ID19694342
  
Advertise on this site.